by emma
24. October 2011 15:04
The FDA has approved Crospon’s EF-800 external channel endoscopic accessory to deploy the company’s EndoFLIP catheters.
John O'Dea, CEO of Crospon, said that the medical device will enable the catheters to be used in “hard to access parts of the gastrointestinal tract”, for example, “measurement of stomas in the stomach created during bariatric surgery procedures”.
The company received FDA and CE Mark approval to market its EndoFLIP EF-900 gastric tube in July 2011, for use in bariatric surgery to provide support for sleeve gastrectomy, and to allow stomach decompression, gastric fluid drainage and removal.
Based in Ireland, Crospon develops minimally-invasive medical devices for monitoring, diagnosis and therapy in gastroenterology.
96e48707-480f-41e2-b533-69c649376b83|0|.0
Tags: endoscopic accessory, FDA, US, USA, Crospon, EF-800, external channel, company, EndoFLIP catheters, John O'Dea, CEO, medical device, catheters, gastrointestinal tract, stomach, bariatric surgery, CE Mark approval, market, sales, sell, gastric tube, stomach decompression, gastric fluid drainage, Ireland, medical devices, monitoring, diagnosis, therapy, gastroenterology
Medtech News
Subscribe